Dr. Farkas’ research focuses on novel concepts that have not yet been thoroughly researched, and it is evident that the focus is on a more promising future for cancer treatment. Current cancer research is wide spread and currently includes areas such as stem-cell research, and immunotherapy (relating to Dr. Farkas’ study of macrophages), however there are other groups researching the area of delivery systems such as antibody drug conjugates. Currently there are many antibody drug conjugates that are being evaluated, however one of the most successful therapies for solid tumor cancers thus far has been monoclonal antibody therapy, which is very similar process, and promises similar or greater success for antibody drug conjugates. In the few cases in which antibody drug conjugates have already been used, the method has proven effective.
Recent comments